Head-to-head
Hims & Hers vs Sequence by WeightWatchers
Hims & Hers and Sequence by WeightWatchers both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Hims & Hers
Higher scoreRanked #5 · Grade B
Best for: Working moms who want a recognizable, phone-native brand with a quick async signup and one clearly posted semaglutide number, and don't need tirzepatide pricing up front.
Visit Hims & HersSequence by WeightWatchers
Ranked #10 · Grade C
Best for: Working moms who specifically want brand-name medication and insurance help and will book a video visit for it, over the fastest, flattest, price-first start.
Visit Sequence by WeightWatchersThe verdict
Hims & Hers edges out Sequence by WeightWatchers on the Rx-Readiness Score, 86 to 77 (B vs C). Working moms who want a recognizable, phone-native brand with a quick async signup and one clearly posted semaglutide number, and don't need tirzepatide pricing up front.
Sequence by WeightWatchers is still a genuine option — the insurance-and-brand heavyweight: a membership that routes you toward FDA-approved product and coverage, with a required video visit. The slowest, most involved path here — and the right one if brand access is the whole point. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Hims & Hers | Sequence by WeightWatchers |
|---|---|---|
| Rx-Readiness Score | 86/100 · B | 77/100 · C |
| Overall rank | #5 | #10 |
| Semaglutide | $199/mo | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Hims & Hers
Ranked #5 · Grade B
What we like
- Slick, phone-native intake you can finish between meetings
- Flat, publicly posted semaglutide price — no dose-tier math
- Mature nationwide operator with a real support stack behind it
The caveats
- Tirzepatide pricing isn't consistently posted, so switching molecules is a question mark
- Compounded only, injection only
- The broader Hims/Hers catalog nudges upsells into a decision that should be one line long
Sequence by WeightWatchers
Ranked #10 · Grade C
What we like
- Real brand-name (Wegovy/Zepbound) access with insurance navigation
- Nationwide reach backed by a household-name company
- Structured program for a more clinically supervised path
The caveats
- A scheduled video visit is required — the hardest slot for a working parent to produce
- Membership plus medication makes the true monthly opaque until you're in
- The slowest first dose of the shortlist
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Hims & Hers and Sequence by WeightWatchers against other providers on our shortlist.
- Hims & Hers vs CoreAge Rx
- Hims & Hers vs Eden
- Hims & Hers vs Trimi Health
- Sequence by WeightWatchers vs Zealthy
- Sequence by WeightWatchers vs Gala Health
- Sequence by WeightWatchers vs Ivim Health
Or browse the full comparison hub.